logo
Select company
Select metric
1.01Cash Ratio
VS
Market
67
Sector
42
Industry
28
History
10
$ 10.96Close
$ 4.26 - $ 15.16 52-Week Range
Ticker Information

Ticker

ENTA

Company Name

ENANTA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENANTA PHARMACEUTICALS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ENTA - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 44.81M1.01$ 44.55M
3/31/2025$ 60.21M1.31$ 45.95M
12/31/2024$ 84.96M1.73$ 49.05M
9/30/2024$ 37.84M0.66$ 57.53M
6/30/2024$ 36.38M0.62$ 58.23M
3/31/2024$ 67.51M1.24$ 54.61M
12/31/2023$ 43.9M0.7$ 62.41M
9/30/2023$ 89.36M1.42$ 62.79M
6/30/2023$ 99.14M1.45$ 68.19M
3/31/2023$ 77.15M2.4$ 32.17M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENANTA PHARMACEUTICALS INC's latest trailing twelve months (TTM) Cash Ratio stands at 3.63.
  • Over the past 5 years, ENANTA PHARMACEUTICALS INC's average Cash Ratio has been 1.62.
  • The median Cash Ratio for ENANTA PHARMACEUTICALS INC during this period was 1.44
  • ENANTA PHARMACEUTICALS INC reached its highest Cash Ratio over the past 5 years at 3.63.
  • The lowest Cash Ratio recorded by ENANTA PHARMACEUTICALS INC in the same timeframe 0.18

ENANTA PHARMACEUTICALS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
THTX : THERATECHNOLOGIES INC 0.24BDTX : BLACK DIAMOND THERAPEUTICS INC 1.83PLX : PROTALIX BIOTHERAPEUTICS INC 0.74ALEC : ALECTOR INC 0.55SGMO : SANGAMO THERAPEUTICS INC 0.84CSBR : CHAMPIONS ONCOLOGY INC 0.45SPRO : SPERO THERAPEUTICS INC 2.09CCCC : C4 THERAPEUTICS INC 1.84TRDA : ENTRADA THERAPEUTICS INC 3.86CELU : CELULARITY INC 0.16

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for ENANTA PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 87.74M ] / LiabilitesC [ $ 24.16M ]
(=) Cash Ratio [ 3.63 ]

ENTA - Cash Ratio, Last 5 years

0.18

Minimum

Jun 30, 2021

3.63

Maximum

Sep 30, 2020

1.62

Average

1.44

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63